SEC Form 4 · accession 0001645627-17-000021
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 23, 2017
Accepted (ET)
Mar 23, 2017 · 3:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0585 | A | 19,855,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.06 | A | 19,856,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.055 | A | 19,857,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.05 | A | 19,858,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.05 | A | 19,859,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.05 | A | 19,860,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.052 | A | 19,861,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.055 | A | 19,862,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.052 | A | 19,863,649 | D |
Table II — derivative securities
No Table II lines on this filing.